Use of tofacitinib for rheumatoid arthritis (RA) may lead to reactivation of hepatitis B virus (HBV), especially among hepatitis B surface antigen-positive (HBsAg+) and HBsAg-negative/hepatitis B core antibody-positive (HBsAg–/HBcAb+) patients, according to a study from Taiwan.
High-dose parenteral vitamin D3 does not reduce mortality, length of hospital stay, and need for intubation among coronavirus disease 2019 (COVID-19) patients with vitamin D deficiency on admission to the intensive care unit (ICU), a recent study has found.
Anticoagulant therapy appears to cut the risk of 29-day mortality in hospitalized COVID-19 patients who are receiving steroids and whose comorbidity and thrombosis risk may differ from those of other ethnic groups, as shown in a Japanese cohort study.
Patients who initiate antiretroviral therapy (ART) on the same day as their HIV diagnosis achieve suboptimal levels of viral load suppression by 12 months, a recent study has found. Such a trend emphasizes the importance of reinforcing treatment adherence among patients.
Disease severity, hyperlactatemia at admission, need for multiple vasoactive drugs, and positive fluid balance are significantly associated with death in children with severe dengue infection admitted to paediatric intensive care unit (PICU), reports a study.
Chemosensory loss due to the coronavirus disease 2019 (COVID-19) seems to recover partially or substantially with time, a recent study has found. Recovery is affected by age and the degree of chemosensory loss.